Combined treatment with colchicine and Herba Taraxaci (Tarazacum mongolicum Hand.-Mazz.) attenuates Behcet's disease-like symptoms in mice and influences the expressions of cytokines

International Immunopharmacology

Volumn 3, Issue 5, 2003, Pages 713-721

  Sohn, Seonghyang ^a   Bang, Dongsik ^b   Lee, Seung Ihm ^a   Kim, Young Ae ^a   Lee, Eun So ^c   Ha, Jee Yong ^e   Kim, Jang Hyun ^d   Choi, Suh Young ^e   Lee, Sungnack ^c  

^a Ajou University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d Dongguk University   (South Korea)

^e NONE

Author keywords

Behcet's disease; Colchicine; Cytokine; Herba Taraxaci; In vivo animal model; Inflammation

Indexed keywords

COLCHICINE; CYTOKINE; CYTOKINE ANTIBODY; HERBA TARAXACI; INTERLEUKIN 4; MESSENGER RNA; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; HERPES SIMPLEX VIRUS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN DISEASE; SPLEEN; SYMPTOM; TARAZACUM MONGOLICUM;

TARAZACUM MONGOLICUM;

EID: 0038054318     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00071-7     Document Type: Article

References (40)

1. Namba K., Ueno T., Okita M. Behcet's disease and streptococcal infection. Jpn. J. Ophthalmol. 30:1986;385-401.
2. Hori Y., Miyazawa S., Nishiyama S., Miyata M., Ishikawa S. Experimental Behcet's disease and ultrastructural X-ray microanalysis of pathological tissues. J. Dermatol. 6:1979;31-37.
3. Lehner T. Behcet's syndrome and autoimmunity. Br. Med. J. 1:1967;465-467.
4. Ohno S., Nakayama E., Sugiura S., Itakura K., Aoki K. Specific histocompatibility antigens associated with Behcet's disease. Am. J. Ophthalmol. 80:1975;636-641.
5. Behcet H. Uber rezidivierende, aphthose durch ein Virus verursachte Geschwure am Mund, am Auge und an den Genitalen. Dermatol. Wochenschr. 105:1937;1152-1157.
6. Sezer F.N. The isolation of a virus as the cause of Behcet's disease. Am. J. Ophthalmol. 36:1953;301-315.
7. Eglin R.P., Lehner T., Subak-Sharpe J.H. Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behcet's syndrome and recurrent oral ulcers. Lancet. 2:1982;1356-1361.
8. Lee S., Bang D., Cho Y.H., Lee E.S., Sohn S. Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patient with Behcet's disease. Arch. Dermatol. Res. 288:1996;179-183.
9. Studd M., McCance D.J., Lehner T. Detection of HSV-1 DNA in patients with Behcet's syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction. J. Med. Microbiol. 34:1991;39-43.
10. Davies U.M., Palmer R.G., Denman A.M. Treatment with acyclovir does not affect orogenital ulcers in Behcets syndrome: a randomized double-blind trial. Br. J. Rheumatol. 27:1988;300-302.
11. Hirohata S., Hashimoto T. Abnormal T cell responses to bacterial superantigens in Behcet's disease. Clin. Exp. Immunol. 112:1998;317-324.
12. Sugi-Ikai N., Nakazawa M., Nakamura S., Ohno S., Minami M. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behcet's disease. IOVS. 39:1998;996-1004.
13. Turan B., Gallati H., Erdi H., Gurler A., Michel B.A., Villiger P.M. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behcet's disease; soluble TNFR-75 as a biological marker of disease activity. J. Rheumatol. 24:1997;128-132.
14. Raziuddin S., Al-Dalaan A., Bahabri S., Siraj A.K., Al-Sedairy S. Divergent cytokine production profile in Behcet's disease. Altered Th1/Th2 cell cytokine pattern. J. Rheumatol. 25:1998;329-333.
15. National Bonchohak Professors, Taraxaci Herba Kim H. 1991;155-156 Jibmoondang, Bonchohak, Seoul.
16. Ou M. Chinese-English manual of common used in traditional Chinese medicine. 1989;649-650 Joint Publishing, Hong Kong.
17. Huang T. A handbook of the composition and pharmacology of common Chinese drugs. 1994;1713 Chinese Medicine and Pharmacology Press, Beijing.
18. Kim H.S. Pharmacology of Korean herbal medicine. 2001;155-156 Jipmundang, Seoul.
19. Hirata Y., Sugita T., Gyo K., Yanagihara N. Experimental vestibular neuritis induced by herpes simplex virus. Acta Otolaryngol. Suppl. 503:1993;79.
20. Sohn S., Lee E.S., Bang D., Lee S. Behcet's disease-like symptoms induced by herpes simplex virus in ICR mice. Eur. J. Dermatol. 8:1998;21-23.
21. Chromczynski P., Sacchi N. Single step methods of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
22. Murray L.J., Lee R., Martens C. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. Eur. J. Immunol. 20:1990;163-170.
23. Chan S.Y., DeBruyne L.A., Goodman R.E., Eichwald E.J., Bishop D.K. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanism of allograft rejection. Transplantation. 59:1995;1155-1161.
24. Moore K.W., Vieira P., Fiorentino D.F., Trounstine M.L., Khan T.A., Mosmann T.R. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr gene BCRFI. Science. 248:1990;1230.
25. Kwon B.S., Wakulchik M., Liu C.C., Persechini P.M., Trapani J.A., Haq A.K.et al. The structure of the mouse lymphocyte pore-forming protein perforin. Biochem. Biophys. Res. Commun. 158:1989;1-10.
26. Watanabe-Fukunaga R., Brannan C.I., Itoh N., Yonehara S., Copeland N.G., Jenkins N.A.et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1992;1274-1279.
27. Bang D. Treatment of Behcet's disease. Yonsei Med. J. 38:1997;401-410.
28. Bonnet M., Ouzan D., Trepo C.H. Plasma exchanges and acyclovir in Behcet's disease. J. Fr. Ophtalmol. 9:1986;15-22.
29. Weinberg A., Bate B.J., Masters H.B., Schneider S.A., Clark J.C., Wren C.G.et al. In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2. Antimicrob. Agents Chemother. 36:1992;2037-2038.
30. Wutzler P., Ulbricht A., Farber I. Antiviral efficacies of famciclovir, valaciclovir, and brivudin in disseminated herpes simplex virus type 1 infection in mice. Intervirology. 40:1997;15-21.
31. Sohn S., Bang D., Lee E.S., Kwon H.J., Lee S.I., Lee S. Experimental studies on the antiviral agent famciclovir in Behcet's disease-like symptoms of ICR mice. Br. J. Dermatol. 145:2001;799-804.
32. Noben-Trauth N., Hu-Li J., Paul W.E. IL-4 secreted from individual naive CD4+ T cells acts in an autocrine manner to induce Th2 differentiation. Eur. J. Immunol. 32:2002;1428-1433.
33. Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by interleukin 10. J. Exp. Med. 174:1991;1549-1555.
34. Moore K.W., O'Garra A., de Waal Malefyt R., Vieira P., Mosmann T.R. Interleukin-10. Annu. Rev. Immunol. 11:1993;165-190.
35. Sohn S., Lee E.S., Kwon H.J., Lee S.I., Bang D., Lee S.J. Expression of Th2 cytokines decreased the development and improved the Behcet's disease-like symptoms induced by herpes simplex virus in mice. J. Infect. Dis. 183:2001;1180-1186.
36. Ayaslioglu E., Turgay M., Duzgun N., Duman M. Expression of Fas antigen (CD95) on peripheral blood lymphocytes in Behcet's disease. Clin. Exp. Rheumatol. 18:2000;538-540.
37. Nakamura S., Sugita M., Matoba H., Tanaka S., Isoda F., Ohno S. Insufficient expression of Fas antigen on helper T cells in Behcet's disease. Br. J. Ophthalmol. 80:1996;174-176.
38. Joseph A., Trapani, Smyth M.J. Functional significance of the perforin/granzyme cell death pathway. Nat. Rev., Immunol. 2:2002;735-747.
39. Henter J.I. Biology and treatment of familial hemophagocytic lymphohistiocytosis: importance of perforin in lymphocyte-mediated cytotoxicity and triggering of apoptosis. Med. Pediatr. Oncol. 38:2002;305-309.
40. Mochizuki M., Morita E., Yamamoto S., Yamana S. Characteristics of T cell lines established from skin lesions of Behcet's disease. J. Dermatol. Sci. 15:1997;9-13.